Investigating the Relationship Between Midazolam Serum Concentrations and Paediatric Delirium in Critically Ill

Sabrina Marongiu1,2, Mathieu S Bolhuis1, Daan J Touw1,2

  • 1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands.

Pediatric Reports
|January 23, 2025
PubMed

Insights

Paediatric delirium (PD) in critically ill children may be linked to sudden drops in midazolam serum concentration. This pilot study suggests that reduced midazolam levels, not just dose, might trigger PD, warranting further research.

Area of Science:

  • Pediatric Intensive Care
  • Pharmacology
  • Neuroscience

Background:

  • Intravenous midazolam is a common sedative for critically ill children.
  • Paediatric delirium (PD) is a potential complication in these patients.
  • The relationship between midazolam levels and PD is not fully understood.

Purpose of the Study:

  • To investigate the association between midazolam serum concentration and the development of new paediatric delirium (PD) in critically ill children.
  • To explore if changes in midazolam levels correlate with PD onset.

Main Methods:

  • Prospective observational pilot study conducted in a Paediatric Intensive Care Unit (PICU).
  • Included 28 critically ill children receiving continuous midazolam.
  • Monitored midazolam serum concentrations and used the Sophia Observation withdrawal Symptoms-Paediatric Delirium (SOS-PD) score to assess for PD.

Main Results:

  • Twenty-five percent (7/28) of children developed new PD, often after midazolam dose reduction.
  • Patients with PD had a lower median midazolam concentration on the day of PD detection compared to the previous day.
  • Similar trends were observed for active midazolam metabolites.

Conclusions:

  • A sudden and significant reduction in midazolam concentration may be associated with the development of PD in critically ill children.
  • Further research in larger cohorts is needed to confirm these findings and understand the underlying mechanisms.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
95
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
355
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
78
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
180
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
172